海扶刀联合化疗后DP-CAR术式切除胰腺癌一例
A Case of Pancreatic Cancer Treated with DP Car after Combined Chemotherapy with HIFU
DOI: 10.12677/ACM.2021.116364, PDF,   
作者: 仲灏辰, 曹广华, 李浩然, 李学良, 郭敬允：青岛大学，山东 青岛；赵 伟*：青岛大学附属医院，山东 青岛
关键词: 胰腺癌；海扶刀；化疗；转化治疗；Pancreatic Cancer； HIFU； Chemotherapy； Conversion Therapy
摘要: 胰腺癌是消化系统中常见恶性肿瘤之一，预后很差，5年生存率小于5%，多数患者在初次就诊时肿瘤已经局部转移、血管侵犯、甚至远处脏器转移，不可切除，而可切除性肿瘤仅15%~20%。本文通过对1例胰腺癌患者经术前以海扶刀和TS方案联合治疗联合DP-CAR术式扩大切除范围从而达到完全切除的目的，提高胰体尾癌患者的生活质量、生存期。
Abstract: Pancreatic cancer is one of the most common malignancies in the digestive system. The prognosis is very poor. The 5-year survival rate is less than 5%. Most of the patients had local metastasis, vascular invasion, or even distant organ metastasis at the first visit, which was unresectable, while only 15%~20% of the tumors were resectable. In order to improve the quality of life and survival time of a patient with pancreatic body and tail cancer, we expanded the scope of resection by combining HIFU and TS with DP-CAR before operation.
文章引用：仲灏辰, 赵伟, 曹广华, 李浩然, 李学良, 郭敬允. 海扶刀联合化疗后DP-CAR术式切除胰腺癌一例[J]. 临床医学进展, 2021, 11(6): 2533-2538. https://doi.org/10.12677/ACM.2021.116364

参考文献

[1] Barman, S., Fatima, I., Singh, A.B., et al. (2021) Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells. International Journal of Molecular Sciences, 22, 4765. [Google Scholar] [CrossRef] [PubMed]
[2] Luu, T. (2021) Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer. Frontiers in Oncology, 11, Article ID: 646399. [Google Scholar] [CrossRef] [PubMed]
[3] Siegel, R.L., Miller, K.D. and Jemal, A. (2017) Cancer Statistics, 2017. CA: A Cancer Journal for Clinicians, 67, 7-30. [Google Scholar] [CrossRef] [PubMed]
[4] Lopez, N.E., Prendergast, C. and Lowy, A.M. (2014) Borderline Resectable Pancreatic Cancer: Definitions and Management. World Journal of Gastroenterology: WJG, 20, 10740-10751. [Google Scholar] [CrossRef] [PubMed]
[5] Ortiz, R., Quiñonero, F., Garcia-Pinel, B., et al. (2021) Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. Cancers (Basel), 13, 2058. [Google Scholar] [CrossRef] [PubMed]
[6] Inoue, Y., Oba, A., Ono, Y., et al. (2021) Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy-Arterial Resection, Arterial Divestment and Total Pancreatectomy. Cancers (Basel), 13, 1818. [Google Scholar] [CrossRef] [PubMed]
[7] Rai, Z.L., Feakins, R., Pallett, L.J., et al. (2021) Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy. Journal of Clinical Medicine, 10, 1609. [Google Scholar] [CrossRef] [PubMed]
[8] Kutschat, A., Johnsen, S.A. and Hamdan, F.H. (2021) Store-Operated Calcium Entry: Shaping the Transcriptional and Epigenetic Landscape in Pancreatic Cancer. Cells, 10, 966. [Google Scholar] [CrossRef] [PubMed]
[9] Arias-Pinilla, G.A. and Modjtahedi, H. (2021) Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities. Cancers (Basel), 13, 1781. [Google Scholar] [CrossRef] [PubMed]
[10] Elsayed, M. and Abdelrahim, M. (2021) The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies. Biomedicines, 9, 389. [Google Scholar] [CrossRef] [PubMed]
[11] 中华人民共和国国家卫生健康委员会. 胰腺癌诊疗规范(2018年版) [J]. 临床肝胆病杂志, 2019, 35(2): 281-293.
[12] Russo, S. and Saif, M.W. (2016) 2016 Gastrointestinal Cancers Symposium: Update on Pancreatic Cancer. Annals of Gastroenterology Quarterly Publication of the Hellenic Society of Gastroenterology, 29, 238-240. [Google Scholar] [CrossRef] [PubMed]
[13] 徐杰. 高强度聚焦超声治疗胰腺癌镇痛疗效体会[J]. 基层医学论坛, 2009(34): 108.
[14] Hoy, S.M. (2014) Albumin-Bound Paclitaxel: A Review of Its Use for the First-Line Combination Treatment of Metastatic Pancreatic Cancer. Drugs, 74, 1757-1768. [Google Scholar] [CrossRef] [PubMed]
[15] 廖小莉, 廖思娜, 李永强, 黄钰晶, 刘志辉, 黎倩, 黄仕新, 韦军葆. 替吉奥单药治疗老年转移性胰腺癌的疗效观察[J]. 广西医科大学学报, 2018, 35(2): 234-237.
[16] 刘艳杰, 陆翰杰. 白蛋白结合紫杉醇联合替吉奥治疗晚期胰腺癌的疗效及安全性观察[J]. 中国临床新医学, 2019, 12(9): 997-1000.
[17] 彭小波, 颜芳, 王斌, 傅强. 白蛋白结合型紫杉醇联合替吉奥治疗吉西他滨治疗失败进展期胰腺癌的临床观察[J]. 中国癌症杂志, 2015, 25(1): 63-66.
[18] 刘甜, 熊琦, 胡毅. 白蛋白结合型紫杉醇联合替吉奥一线治疗老年晚期胰腺癌患者的临床观察[J]. 现代肿瘤医学, 2018(5): 722-725.
[19] 庄兴俊, 欧娟娟, 高云姝, 高百春, 顾军. 高强度聚焦超声联合放疗治疗35例胰腺癌的临床分析[J]. 重庆医学, 2010, 39(3): 283-284.
[20] Hess, K.R., Varadhachary, G.R., Taylor, S.H., Wei, W., Raber, M.N., Lenzi, R. and Abbruzzese, J.L. (2006) Metastatic Patterns in Adenocarcinoma. Cancer, 106, 1624-1633. [Google Scholar] [CrossRef] [PubMed]
[21] Ammori, J.B., Colletti, L.M., Zalupski, M.M., Eckhauser, F.E., Greenson, J.K., Dimick, J., Lawrence, T.S. and McGinn, C.J. (2003) Surgical Resection Following Radiation Therapy with Concurrent Gemcitabine in Patients with Previously Unresectable Adenocarcinoma of the Pancreas. Journal of Gastrointestinal Surgery, 7, 766-772. [Google Scholar] [CrossRef] 
[22] Evans, D.B., Wolff, R.A. and Crane, C.H. (2001) Neoadjuvant Strategies for Pancreatic Cancer.
[23] Yoshiya, S., Fukuzawa, K., Inokuchi, S., Kosai-Fujimoto, Y., Sanefuji, K., Iwaki, K., Motohiro, A., Itoh, S., Harada, N. and Ikegami, T. (2019) Efficacy of Neoadjuvant Chemotherapy in Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP-CAR) for Locally Advanced Pancreatic Cancer. Journal of Gastrointestinal Surgery, 24, 1605-1611. [Google Scholar] [CrossRef] [PubMed]
[24] Powell-Brett, S., Pande, R. and Roberts, K.J. (2021) Achieving “Marginal Gains” to Optimise Outcomes in Resectable Pancreatic Cancer. Cancers (Basel), 13, 1669. [Google Scholar] [CrossRef] [PubMed]
[25] Ocuin, L.M., Miller-Ocuin, J.L., Novak, S.M., Bartlett, D.L., Marsh, J.W., Tsung, A., Lee, K.K., Hogg, M.E., Zeh, H.J. and Zureikat, A.H. (2016) Robotic and Open Distal Pancreatectomy with Celiac Axis Resection for Locally Advanced Pancreatic Body Tumors: A Single Institutional Assessment of Perioperative Outcomes and Survival. HPB, 18, 835-842. [Google Scholar] [CrossRef] [PubMed]

为你推荐